Cargando…
Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss
Noise trauma is the most common cause of hearing loss in adults. There are no known FDA approved drugs for prevention or rescue of noise-induced hearing loss (NIHL). In this study, we provide evidence that implicates stress signaling molecules (TRPV1, NOX3, and TNF-α) in NIHL. Furthermore, we provid...
Autores principales: | Dhukhwa, Asmita, Bhatta, Puspanjali, Sheth, Sandeep, Korrapati, Krishi, Tieu, Coral, Mamillapalli, Chaitanya, Ramkumar, Vickram, Mukherjea, Debashree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786284/ https://www.ncbi.nlm.nih.gov/pubmed/31632242 http://dx.doi.org/10.3389/fncel.2019.00444 |
Ejemplares similares
-
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019) -
Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea
por: Bhatta, Puspanjali, et al.
Publicado: (2019) -
Local Drug Delivery for Prevention of Hearing Loss
por: Rybak, Leonard P., et al.
Publicado: (2019) -
Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
por: Dhukhwa, Asmita, et al.
Publicado: (2021) -
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018)